Arena Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Five
Arena Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Five of $2.12 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive · last filed 2022-02-23
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $2.12M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $2.07M.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Five $2.28M.
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Five $2.57M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Five |
|---|---|
| 2021-12-31 | $2.12M 10-K · filed 2022-02-23 |
| 2020-12-31 | $2.07M 10-K · filed 2021-02-23 |
| 2019-12-31 | $2.28M 10-K · filed 2020-02-27 |
| 2019-09-30 | $2.57M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.46M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.02M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.00M 10-Q · filed 2019-11-08 |